Decoy Therapeutics is trading 11.43% lower at $3.41 after its September 23, 2026 warrant-inducement financing created dilution pressure.

  • The transaction generated approximately $3.85 million by exercising existing warrants at $3.25 and issued new warrants covering up to 2,368,868 shares.
  • A correction confirmed the new warrants became exercisable immediately upon issuance, intensifying selling pressure after the September 23 rally.
  • Biotechnology weakness and risk-off macro conditions added headwinds.